Article Per Year (5 Year)
p-Index From 2019 - 2024
0.23
P-Index
This Author published in this journals
All Journal Berkala Ilmiah Mahasiswa Farmasi
Feliadewi Ruth
Universitas Ma Chung
Biochemistry, Genetics & Molecular Biology Chemistry Health Professions Immunology & microbiology Medicine & Pharmacology

Published : 1 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 1 Documents
Search

 1 
Reaksi Obat yang Tidak Dikehendaki (Rotd) pada Pasien Rawat Jalan Penyakit Ginjal Kronis Tahap Akhir di Komunitas Pasien Cuci Darah Indonesia Cabang Jawa Timur : Metode Cross Feliadewi Ruth; Martanty Aditya; Muhammad Hilmi Aftoni
Berkala Ilmiah Mahasiswa Farmasi Indonesia Vol 8 No 1 (2021): Berkala Ilmiah Mahasiswa Farmasi Indonesia (BIMFI)
Publisher : Ikatan Senat Mahasiswa Farmasi Seluruh Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.48177/bimfi.v8i1.60

Abstract

Introduction: Adverse Drug Reaction (ADR) is a side effect arising from the use of drugs with normal doses. ADR might decrease quality of life, increase frequency to doctor, and death. ADR in patients with End-Stage Renal Disease (ESRD) has not been much studied. ESRD have a greater risk of experiencing ADR because the kidneys have decreased and the drugs can accumulate in the body. Study was conducted to determine the incidence of ADR in outpatients in the final stage of ESRD. Methods: This study use cross sectional method. Demographic data and ADR status were collected from members of the Indonesian Dialysis Patient Community in East Java. Drug data had grouped into drugs that potential and no potential for ADR, then an analysis with a Chi-square test to find correlation of potential ROTD drugs and the incidence of ADR in outpatients in ESRD. Result: There are 62 respondents in this study who fulfilled the inclusion. From the test between the characteristic and ADR is a correlation between allergies and ADR (p = 0.018). Based on the results of the Chi-square test between the use of potential ADR drugs with the incidence of ADR in outpatients in the final stage of the patient did not have a correlation (p value = 0.812). Conclusion: From this study it can be concluded that there is no correlation between potential ROTD drugs with the incidence of ROTD in end-stage CKD outpatients (p = 0.812).
Co-Authors Aftoni, Muhammad Hilmi Martanty Aditya, Martanty